Chargement en cours...
Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin
BACKGROUND: Azithromycin (AZI) is recommended with Ceftriaxone (CRO) for treatment of uncomplicated gonococcal urethritis and cervicitis in the United States (US) and an AZI susceptibility breakpoint is needed. Neither the FDA (Food and Drug Administration) nor the CLSI (Clinical and Laboratory Stan...
Enregistré dans:
| Publié dans: | Clin Infect Dis |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785360/ https://ncbi.nlm.nih.gov/pubmed/30963175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz292 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|